相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial
Wei-Chen Tai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication
Jung Won Lee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Helicobacter pylori Infection
Sheila E. Crowe
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication
Vincenzo De Francesco et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
World trends for H-pylori eradication therapy and gastric cancer prevention strategy by H-pylori test-and-treat
Hidekazu Suzuki et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Acquisition of double mutation in gyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimens
Hideki Mori et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
Alessia Savoldi et al.
GASTROENTEROLOGY (2018)
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report
P. Malfertheiner et al.
GUT (2017)
Antibiotic resistance and gyrA mutation affect the efficacy of 10-day sitafloxacin-metronidazole-esomeprazole therapy for Helicobacter pylori in penicillin allergic patients
Hideki Mori et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
Primary Antibiotic Resistance of Helicobacter pylori in China
Yi Hu et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA Mutation
Hideki Mori et al.
HELICOBACTER (2016)
Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial
Ju Yup Lee et al.
BMC GASTROENTEROLOGY (2016)
The Changing Profile of Helicobacter pylori Antibiotic Resistance in Singapore: A 15-Year Study
Tiing Leong Ang et al.
HELICOBACTER (2016)
Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study
Yue-Xi Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Factors Affecting First-Line Triple Therapy of Helicobacter pylori Including CYP2C19 Genotype and Antibiotic Resistance
Ju Yup Lee et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Antimicrobial Resistance and Characteristics of Eradication Therapy of Helicobacter pylori in Japan: A Multi-Generational Comparison
Takuma Okamura et al.
HELICOBACTER (2014)
Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group)
Takashi Kawai et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition
Sang Gyun Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study
Xiao Liang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption
Francis Megraud et al.
GUT (2013)
Prevalence of Primary and Secondary Antimicrobial Resistance of Helicobacter pylori in Korea from 2003 through 2012
Jung Won Lee et al.
HELICOBACTER (2013)
Efficacy of Sitafloxacin-Based Rescue Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies
Juntaro Matsuzaki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Dual therapy for third-lineHelicobacter pylorieradication and urea breath test prediction
Toshihiro Nishizawa
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Enhancement of Amoxicillin Resistance after Unsuccessful Helicobacter pylori Eradication
Toshihiro Nishizawa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Comparison of the Efficacy of the Two Tetracycline-Containing Sequential Therapy Regimens for the Eradication of Helicobacter Pylori: 5 days Versus 14 days Amoxicillin
Zueleyha A. Cetinkaya et al.
HELICOBACTER (2010)
The Evolution of Helicobacter pylori Antibiotics Resistance Over 10 Years in Beijing, China
Wen Gao et al.
HELICOBACTER (2010)
Sitafloxacin and Garenoxacin May Overcome the Antibiotic Resistance of Helicobacter pylori with gyrA Mutation
Hidekazu Suzuki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Moxifloxacin-Containing Triple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate
Hyuk Yoon et al.
HELICOBACTER (2009)
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer:: an open-label, randomised controlled trial
Kazutoshi Fukase et al.
LANCET (2008)
The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection
John J. Carothers et al.
CLINICAL INFECTIOUS DISEASES (2007)
Helicobacter pylori and antimicrobial resistance:: molecular mechanisms and clinical implications
Monique M. Gerrits et al.
LANCET INFECTIOUS DISEASES (2006)
Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea
Nayoung Kim et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions
Wei-cheng You et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients
Jung Mogg Kim et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients
JM Kim et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Factors predicting progression of gastric intestinal metaplasia:: results of a randomised trial on Helicobacter pylori eradication
WK Leung et al.
GUT (2004)
Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea
JM Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections
BJ McMahon et al.
ANNALS OF INTERNAL MEDICINE (2003)
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea
JJ Kim et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Long-term effects of Helicobacter pylori eradication on intestinal metaplasia in patients with duodenal and benign gastric ulcers
N Kim et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
分享论文
